Side effects of topical steroids ppt

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

Common (1% to 10%): Skin discomfort, acne/folliculitis, telangiectasia, skin atrophy, dry skin
Uncommon (% to 1%): Local signs of irritation, pruritus, urticaria
Frequency not reported: Stria, purpura, contact dermatitis, pigmentation changes, pustular eruptions, hypertrichosis, irritant dermatitis
Postmarketing reports: Erythema, alopecia, pain of skin, skin exfoliation, chapped skin, scaling, induration/papulation,
lichenification, psoriasis (aggravation) plaque elevation, excoriation, rash, hair color changes, skin tightness [ Ref ]

Use of PENLAC® NAIL LACQUER (ciclopirox) Topical Solution, 8%, for 48 additional weeks was evaluated in an open-label extension study conducted in patients previously treated in the vehicle-controlled studies. Three percent (9/281) of subjects treated with PENLAC® NAIL LACQUER (ciclopirox) Topical Solution, 8%, experienced at least one TEAE that the investigator thought was causally related to the test material. Mild rash in the form of periungual erythema (1% [2/281]) and nail disorders (1% [4/281]) were the most frequently reported. Four patients discontinued because of TEAEs. Two of the four had events considered to be related to test material: one patient's great toenail "broke away" and another had an elevated creatine phosphokinase level on Day 1 (after 48 weeks of treatment with vehicle in the previous vehicle-controlled study).

In controlled clinical trials , the total incidence of adverse reactions associated with the use of METROCREAM® (metronidazole topical cream) Topical Cream was approximately 10%. Skin discomfort (burning and stinging) was the most frequently reported event followed by erythema , skin irritation, pruritus and worsening of rosacea . All individual events occurred in less than 3% of patients. The following additional adverse experiences have been reported with the topical use of metronidazole: dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea .

Side effects of topical steroids ppt

side effects of topical steroids ppt

In controlled clinical trials , the total incidence of adverse reactions associated with the use of METROCREAM® (metronidazole topical cream) Topical Cream was approximately 10%. Skin discomfort (burning and stinging) was the most frequently reported event followed by erythema , skin irritation, pruritus and worsening of rosacea . All individual events occurred in less than 3% of patients. The following additional adverse experiences have been reported with the topical use of metronidazole: dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea .

Media:

side effects of topical steroids pptside effects of topical steroids pptside effects of topical steroids pptside effects of topical steroids pptside effects of topical steroids ppt